Kuan-Lin Huang, PhD
- ASSISTANT PROFESSOR | Genetics and Genomic Sciences
Research Topics:
Alzheimer's Disease, Bioinformatics, Biomedical Informatics, Brain, Cancer, Cancer Genetics, Computational Biology, Epidemiology, Epigenomics, Gene editing, Genomics, Mass Spectrometry, Mathematical and Computational Biology, Neural Networks, Neurology, Personalized Medicine, Pharmacogenomics, Phosphorylation, Post-Transcriptional Processing, Protein Structure/Function, Proteomics, Systems Biology, TranslationKuan-Lin Huang is an Assistant Professor with the Department of Genetics and Genomic Sciences and a faculty member of the Icahn Genomics Institute.
Huang Lab | Computational Omics: ComputationalOmicsLab.org
Multi-Disciplinary Training Areas
Artificial Intelligence and Emerging Technologies in Medicine [AIET], Cancer Biology [CAB], Disease Mechanisms and Therapeutics (DMT), Genetics and Genomic Sciences [GGS], Neuroscience [NEU]Education
BA, Wesleyan University
PhD, Washington University in St. Louis
Postdoc, Washington University in St. Louis
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Huang during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Company Founder:
- Open Box Science
Scientific Advisory Board:
- Open Box Science
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.